Dr.med. ID: 2597367
Niklas Börschel
Publications
- 2022
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
Schönlein, M., Wrage, V., Ghandili, S., Mellinghoff, S. C., Brehm, T. T., Leypoldt, L. B., Utz, N., Schrader, R. M., Alsdorf, W., Börschel, N., Bußmann, L., Schönrock, M., Perlick, D., Schön, G., Verpoort, K., Lütgehetmann, M., Schulze Zur Wiesch, J., Weisel, K. C., Bokemeyer, C., Schafhausen, P. & Sinn, M., 13.06.2022, In: CANCER CELL. 40, 6, p. 581-583 3 p.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
- 2015
Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature
Börschel, N., Schwöppe, C., Zerbst, C., Angenendt, L., Kessler, T., Klapper, W., Giovannoni, L., Elia, G., Neri, D., Berdel, W. E., Mesters, R. M. & Schliemann, C., 07.2015, In: Leukemia research. 39, 7, p. 739-48 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research